top of page
developing therapeutic antibodies
antibodies are our immune system’s most sophisticated weapon against diseases and represent highly promising, but difficult to source therapeutics against a wide range of conditions. memo therapeutics is a biotech company developing best-in-class therapeutic antibodies to transform the lives of patients with virus infections and cancer.
transforming the lives of patients
its unique platform technology can capture and bank complete antibody repertoires of individual humans and animals, enabling fast and cost-efficient discovery of highly relevant therapeutic antibody candidates, and increasing the probability of success in subsequent clinical development.
rac II
biotech
2015
2012
fund
sector
invested in
founded
bottom of page